Seeking Alpha

Johnson & Johnson (JNJ -0.1%) finishes the day relatively flat, despite saying earlier that...

Johnson & Johnson (JNJ -0.1%) finishes the day relatively flat, despite saying earlier that its Janssen Pharmaceuticals unit has been granted a positive opinion by the CHMP of the European Medicines Agency recommending approval of its prostate cancer treatment Zytiga.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|